Shopping Cart
Remove All
Your shopping cart is currently empty
BMS-566419 is an acridone-based inhibitor of inosine 5'-monophosphate dehydrogenase, a rate-limiting enzyme in de novo guanosine nucleotide biosynthesis, and through suppression of lymphocyte proliferation it has demonstrated clinical utility as a research compound for investigating immunosuppression mechanisms and therapeutic strategies in transplant rejection.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | $896 | 35 days | 35 days |
| Description | BMS-566419 is an acridone-based inhibitor of inosine 5'-monophosphate dehydrogenase, a rate-limiting enzyme in de novo guanosine nucleotide biosynthesis, and through suppression of lymphocyte proliferation it has demonstrated clinical utility as a research compound for investigating immunosuppression mechanisms and therapeutic strategies in transplant rejection. |
| In vitro | In enzymatic assays, BMS-566419 specifically inhibited human IMPDH II with an IC50 of approximately 10 nM [1]. |
| In vivo | In a rat model of Collagen-Induced Arthritis (CIA), oral administration of BMS-566419 reduced joint inflammation and disease progression. Pharmacokinetic studies demonstrated oral bioavailability for the compound [1]. |
| Synonyms | BMS566419, BMS 566419 |
| Molecular Weight | 487.57 |
| Formula | C28H30FN5O2 |
| Cas No. | 566161-24-8 |
| Smiles | O=C(NC(C1=CN=C(C=C1)N2CCN(CC)CC2)(C)C)C=3C=C4NC=5C=CC=CC5C(=O)C4=CC3F |
| Storage | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 10 mg/mL (20.51 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.